EXHIBIT 10.1 ------------ PATENT LICENSE AGREEMENT THIS AGREEMENT made and entered into and effective as of August 13, 2008, is by and between Network-1 Security Solutions, Inc., a Delaware corporation (the "Licensor") and Microsemi Corporation, a...Patent License Agreement • August 15th, 2008 • Network 1 Security Solutions Inc • Services-prepackaged software • New York
PATENT LICENSE AGREEMENT n° C-00061906Patent License Agreement • March 12th, 2019 • Cellectis S.A. • Biological products, (no disgnostic substances)
IP is owner of patents and patent applications relating to a method of homologous recombination. IP has already granted exploitation rights for these patents and patent application to third parties for specific applications and now wishes to share this technology with a new industrial partner.
RECITALSPatent License Agreement • November 12th, 2002 • Majestic Safe-T-Products LTD • California
EXHIBIT 10.53 CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND SEPARATELY FILED WITH THE COMMISSION. NARROWBAND CDMA AND THIRD GENERATION PATENT LICENSE AGREEMENT BETWEEN INTERDIGITAL TECHNOLOGY CORPORATION and NEC CORPORATION Dated and...Patent License Agreement • July 2nd, 2003 • Interdigital Communications Corp • Patent owners & lessors • Delaware
Exhibit 10.10 PATENT LICENSE AGREEMENTPatent License Agreement • January 31st, 2001 • Wavesplitter Technologies Inc • Semiconductors & related devices • California
CONFIDENTIAL TREATMENT REQUESTED. INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH “****” OR OTHERWISE CLEARLY INDICATED. AN UNREDACTED VERSION OF THIS DOCUMENT HAS ALSO BEEN PROVIDED TO THE SECURITIES AND...Patent License Agreement • July 23rd, 2014 • MetaStat, Inc. • Semiconductors & related devices • Massachusetts
This Agreement, effective as of the date set forth above the signatures of the parties below (the "EFFECTIVE DATE"), is between the Massachusetts Institute of Technology ("M.I.T."), a corporation organized and existing under the laws of the State of Massachusetts, with a principal office at 77 Massachusetts Avenue, Cambridge, MA 02139-4307, Albert Einstein College of Medicine of Yeshiva University, a Division of Yeshiva University, a corporation organized and existing under the laws of the State of New York, having a place of business at 1300 Morris Park Avenue, Bronx, New York 10461 (“EINSTEIN”), Montefiore Medical Center, a corporation organized and existing under the laws of the State of New York, having an office and place of business at 111 East 210th Street, Bronx, New York 10467 (“MONTEFIORE”) (M.I.T., EINSTEIN, and MONTEFIORE shall be referred to individually and collectively as “THE PARTIES”), and MetaStat BioMedical, Inc., a corporation organized and existing under the laws o
PUBLIC HEALTH SERVICE PATENT LICENSE AGREEMENT-NONEXCLUSIVE COVER PAGEPatent License Agreement • December 28th, 2011 • Mri Interventions, Inc. • Surgical & medical instruments & apparatus • District of Columbia
This Patent License Agreement, hereinafter referred to as the “Agreement”, consists of this Cover Page, an attached Agreement, a Signature Page, Appendix A (List of Patent(s) or Patent Application(s)), Appendix B (Fields of Use and Territory), Appendix C (Royalties), Appendix D ((Benchmarks and Performance), Appendix E (Commercial Development Plan), Appendix F (Example Royalty Report), and Appendix G (Royalty Payment Options). The Parties to this Agreement are:
PATENT LICENSE AGREEMENT by and between TECHNIPFMC PLC AND TECHNIP ENERGIES N.V. Dated as of February 15, 2021Patent License Agreement • March 25th, 2022 • Technip Energies N.V. • Services-engineering services • New York
PATENT LICENSE AGREEMENTPatent License Agreement • May 23rd, 2005 • SmartMetric, Inc. • Miscellaneous manufacturing industries
AGREEMENT made and entered into as of the 1st day of August 2004, with revisions dated December 33, 2004 by and between Applied Cryptology, Inc., a Nevada corporation having its principal offices at [address] (the “Licensor”), and SmartMetric, Inc., a Nevada corporation having its principal offices at 67 Wall Street, Level 22, New York, New York 10005 (the “Company”).
UNIVERSITY of PENNSYLVANIA PATENT LICENSE AGREEMENTPatent License Agreement • August 10th, 2010 • Aegerion Pharmaceuticals, Inc. • Pharmaceutical preparations • Pennsylvania
This Patent License Agreement (this “Agreement”) is between The Trustees of the University of Pennsylvania, a Pennsylvania nonprofit corporation (“Penn”), and Aegerion Pharmaceuticals, Inc, a Delaware corporation (“Company”). This Agreement is effective on May 19, 2006 (the “Effective Date”).
START-UP PATENT LICENSE AGREEMENT – EXCLUSIVEPatent License Agreement • April 29th, 2015 • District of Columbia
This Start-Up Patent License Agreement, hereinafter referred to as the “Agreement”, consists of this Cover Page, an attached Agreement, a Signature Page, Appendix A (List of Patent(s) or Patent Application(s)), Appendix B (Fields of Use and Territory), Appendix C (Royalties), Appendix D (Benchmarks and Performance), Appendix E (Commercial Development Plan), Appendix F (Example Royalty Report), and Appendix G (Royalty Payment Options). The Parties to this Agreement are:
PATENT LICENSE AGREEMENTPatent License Agreement • July 6th, 2020
This Agreement is entered into between the U.S. Government, as represented by the U.S. Department of Agriculture, Agricultural Research Service (hereinafter referred to as “USDA”) and (company name), a (state) corporation having offices at (street address, city, and state) (hereinafter referred to as “COMPANY”).
PATENT LICENSE AGREEMENT For NanoPulse TechnologyPatent License Agreement • May 3rd, 2016 • Pulse Biosciences, Inc. • Surgical & medical instruments & apparatus • California
PATENT LICENSE AGREEMENTPatent License Agreement • September 29th, 2022
[insert name], a company established and existing under the laws of [insert country], commercial registry code [insert code], located at [insert address] (Licensor), represented by [insert position and name], and
PATENT LICENSE AGREEMENTPatent License Agreement • July 6th, 2020 • District of Columbia
This Agreement is entered into between the U.S. Government, as represented by the U.S. Department of Agriculture, Agricultural Research Service (hereinafter referred to as “USDA”) and (company name), a (state) corporation having offices at (street address, city, and state) (hereinafter referred to as “COMPANY”).
CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (i) NOT MATERIAL AND (ii) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. OMISSIONS ARE DENOTED IN BRACKETS THROUGHOUT THIS EXHIBIT....Patent License Agreement • June 29th, 2020 • ScoutCam Inc. • Optical instruments & lenses
This PATENT LICENSE AGREEMENT (“Agreement”), is dated as of December 1, 2019, made effective as of December 1, 2019 (“Effective Date”), by and between Medigus Ltd., a company organized under the laws of the State of Israel (“Licensor”) and ScoutCam Ltd., a company organized under the laws of the State of Israel (“Licensee”). Licensor and Licensee are each referred to herein separately as “Party” and are referred to herein collectively as the “Parties.”
THIS PATENT LICENSE AGREEMENT (the "Agreement") MADE BETWEEN:Patent License Agreement • May 1st, 2023 • New York
EVRYTHNG LIMITED, a corporation organized under the laws of the United Kingdom (hereinafter "EVRYTHNG") whose address is: Unit 4, 122 East Road, London N1 6FB, United Kingdom,
PATENT LICENSE AGREEMENTPatent License Agreement • September 21st, 2018 • Guardant Health, Inc. • Services-medical laboratories • New York
THIS PATENT LICENSE AGREEMENT (the “Agreement”) is made effective as of January 1, 2017 (the “Effective Date”), by and between Keygene N.V. (“KeyGene”), a company organized and existing under the laws of The Netherlands and having its registered offices at Agro Business Park 90, 6708 PW Wageningen, The Netherlands, and Guardant Health, Inc., a company incorporated under the laws of the State of Delaware, and having an address at 505 Penobscot Drive, Redwood City, CA 94063 (“Licensee”) and relates to KeyGene Technology as defined hereinafter. KeyGene and Licensee may be referred to herein individually as a “Party” or collectively as the “Parties.”
Patent License AgreementPatent License Agreement • April 16th, 2021 • AIkido Pharma Inc. • Services-commercial physical & biological research • New York
This Patent License Agreement (this “Agreement”) is effective as of the date of the last signature on the signature page (the “Effective Date”), and is made by and between SILO PHARMA INC., a Delaware Corporation, and SILO PHARMA, INC., a Florida Corporation, and their Affiliates/Subsidiaries, as defined below, with principal executive offices located at 560 Sylvan Avenue, Suite 3160, Englewood Cliffs, New Jersey 07632 (collectively, “Licensor”), on the one hand, and AIKIDO PHARMA INC., a Delaware corporation, principal executive offices located at One Rockefeller Plaza, 11th Floor, New York, New York 10020 (“Licensee”), on the other hand (collectively, the “Parties,” or each, individually, a “Party”).
PATENT LICENSE AGREEMENTPatent License Agreement • January 21st, 2009 • Impax Laboratories Inc • Pharmaceutical preparations • New York
This Patent License Agreement, dated as of March 30, 2007 (the “Patent License Agreement”), is by and among Purdue Pharma L.P., a Delaware limited partnership, The P.F. Laboratories, Inc., a New Jersey corporation, Purdue Pharmaceuticals L.P., a Delaware limited partnership (the foregoing are individually and collectively referred to as the “Purdue Companies”), and IMPAX Laboratories, Inc., a Delaware corporation (“IMPAX”). The Purdue Companies and IMPAX are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
Patent License Agreement for Startups Agreement No.Patent License Agreement • May 5th, 2020 • Texas
This Patent and Technology License Agreement (“Agreement”) is between the Board of Regents (“Board”) of The University of Texas System (“System”), an agency of the State of Texas, whose address is 201 West 7th Street, Austin, Texas 78701, on behalf of The University of Texas at El Paso (“UTEP”), a component institution of System (Board and UTEP together “Licensor”) and [Company Name] a [State] corporation with its principal place of business at [Company Address] (“Licensee”) (collectively, “Parties”, or singly, “Party”).
THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. PATENT LICENSE AGREEMENT BETWEEN GENOCEA...Patent License Agreement • January 13th, 2014 • Genocea Biosciences, Inc. • Biological products, (no disgnostic substances) • Washington
This patent license agreement (the “Agreement”) is dated and effective as of January 27, 2010 (the “Effective Date”) and is made by and between the University of Washington, a public institution of higher education and an agency of the state of Washington, acting through UW TechTransfer, Technology Licensing (“University”), and Genocea Biosciences, Inc., a Delaware corporation with its principal place of business at 161 First Street, Suite 2C, Cambridge, MA 02142 (“Company”), (individually each a “Party” or collectively, the “Parties”).
ContractPatent License Agreement • May 21st, 2013 • Bluebird Bio, Inc. • Biological products, (no disgnostic substances) • Massachusetts
CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED.
Exhibit 10.2 PATENT LICENSE AGREEMENTPatent License Agreement • August 31st, 2000 • Comdial Corp • Telephone & telegraph apparatus
PUBLIC HEALTH SERVICE PATENT LICENSE AGREEMENT — EXCLUSIVE COVER PAGEPatent License Agreement • January 4th, 2016 • Bavarian Nordic a/S / ADR • Biological products, (no disgnostic substances) • District of Columbia
This Patent License Agreement, hereinafter referred to as the “Agreement”, consists of this Cover Page, an attached Agreement, a Signature Page, Appendix A (List of Patent(s) or Patent Application(s)), Appendix B (Fields of Use and Territory), Appendix C (Royalties), Appendix D (Benchmarks and Performance), Appendix E (Commercial Development Plan), Appendix F (Example Royalty Report), and Appendix G (Royalty Payment Options). The Parties to this Agreement are:
PUBLIC HEALTH SERVICE PATENT LICENSE AGREEMENT—EXCLUSIVE COVER PAGEPatent License Agreement • September 10th, 2013 • Can-Fite BioPharma Ltd. • Pharmaceutical preparations • District of Columbia
This Patent License Agreement, hereinafter referred to as the “Agreement”, consists of this Cover Page, an attached Agreement, a Signature Page, Appendix A (List of Patent(s) and/or Patent Application(s)), Appendix B (Fields of Use and Territory), Appendix C (Royalties), Appendix D (Modifications), Appendix E (Benchmarks), and Appendix F (Commercial Development Plan). The Parties to this Agreement are:
Patent License AgreementPatent License Agreement • February 26th, 2008 • Massachusetts
This Patent License Agreement, effective as of ("Effective Date"), is between Mercury Computer Systems, Inc. ("Mercury"), having a principal place of business at
PATENT LICENSE AGREEMENTPatent License Agreement • July 15th, 2009 • Texas
THIS Agreement is between the Board of Regents ("Board") of The University of Texas System ("System"), an agency of the State of Texas, whose address is 210 West 7th Street, Austin, Texas 78701, and ________________ , a _____________ corporation having a principal place of business located at _______________ ("Licensee").
MASSACHUSETTS INSTITUTE OF TECHNOLOGY AND ENUMERAL BIOMEDICAL CORP EXCLUSIVE PATENT LICENSE AGREEMENTPatent License Agreement • October 31st, 2014 • Enumeral Biomedical Holdings, Inc. • Pharmaceutical preparations • Massachusetts
This Agreement, effective as of the date set forth above the signatures of the parties below (the "EFFECTIVE DATE"), is between the Massachusetts Institute of Technology ("M.I.T."), a Massachusetts corporation, with a principal office at 77 Massachusetts Avenue, Cambridge, MA 02139-4307 and Enumeral Biomedical Corp., Inc. ("COMPANY"), a Delaware corporation, with a principal place of business at 1450 Broadway, 24th Floor, New York, NY 10018.
BETWEENPatent License Agreement • July 19th, 2002 • Lexar Media Inc • Photographic equipment & supplies • California
…*…] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED. PATENT LICENSE...Patent License Agreement • October 11th, 2013 • Cardiodx Inc • Services-medical laboratories • California
[…*…] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.
PUBLIC HEALTH SERVICE PATENT LICENSE AGREEMENT —EXCLUSIVE COVER PAGEPatent License Agreement • January 8th, 2014 • Kinemed Inc • Services-commercial physical & biological research • District of Columbia
This Patent License Agreement, hereinafter referred to as the “Agreement”, consists of this Cover Page, an attached Agreement, a Signature Page, Appendix A (List of Patent(s) or Patent Application(s)), Appendix B (Fields of Use and Territory), Appendix C (Royalties), Appendix D (Benchmarks and Performance), Appendix E (Commercial Development Plan), Appendix F (Example Royalty Report), and Appendix G (Royalty Payment Options). The Parties to this Agreement are:
PATENT LICENSE AGREEMENTPatent License Agreement • January 15th, 2021 • Lucira Health, Inc. • In vitro & in vivo diagnostic substances
THIS PATENT LICENSE AGREEMENT (this “Agreement”), dated as of this 15th day of July, 2020 (the “Effective Date”), by and between Eiken Chemical Co., Ltd., a corporation organized and existing under the laws of Japan with its principal place of business at 19-9, Taito 4-chome, Taito-ku, Tokyo, Japan (“Eiken”) and Lucira Health, Inc., a corporation organized and existing under the laws of Delaware with its principal place of business at 1412 62nd Street, Emeryville, CA 94608 U.S.A. (“Lucira”).
PATENT LICENSE AGREEMENTPatent License Agreement • April 8th, 2015 • Myecheck, Inc. • Services-business services, nec
This agreement is made and entered into between Edward R. Starrs (hereinafter called “Licensor”) whose address is 674 Platt Circle, El Dorado Hills, CA 95762, and
NONEXCLUSIVE PATENT LICENSE AGREEMENTPatent License Agreement • February 17th, 2012 • Massachusetts
This Agreement, effective as of the date set forth above the signatures of the parties below (the "EFFECTIVE DATE"), is between the Massachusetts Institute of Technology ("M.I.T."), a Massachusetts corporation, with a principal office at 77 Massachusetts Avenue, Cambridge, MA 02139-4307 and ("COMPANY"), a corporation, with a principal place of business at
